2026

Publication

BET inhibitor OPN-2853 in advanced solid tumors and lymphoma: results from the phase 1b PLX124-01 trial

https://link.springer.com/article/10.1007/s00280-026-04871-3?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=nonoa_20260306&utm_content=10.1007%2Fs00280-026-04871-3
Publication

BET inhibition blunts antibody production and macrophage-mediated fibrosis to restore lung function in murine cGVHD

https://ashpublications.org/blood/article-abstract/doi/10.1182/blood.2025031983/566894/BET-inhibition-blunts-antibody-production-and?redirectedFrom=fulltext